PatientEngagementHIT

Patient Financial Responsibility

Out-of-Pocket Patient Spend Soars as Utilization is Unchanged

February 14, 2019 - Healthcare costs and out-of-pocket patient spending is increasing, despite consistent healthcare utilization, according to the Health Care Cost Institute (HCCI) 2017 Health Care Cost and Utilization Report. The report, which looked at claims data for about 40 million individuals on employer-sponsored health plans, revealed that healthcare spending is continuing to rise. “Health...


More Articles

76% of Patients Benefit from Drug Price Transparency Technology

by Sara Heath

Providing point-of-care drug price transparency may be getting closer to a reality, as more providers adopt the technology necessary to view such information, according to a Surescripts report released this week at HIMSS. Price...

Despite Coverage Gains, Underinsurance Hampers Patient Care Access

by Sara Heath

Although more patients have access to health insurance, fewer have access to quality, comprehensive health plans just eight years after the passage of the Affordable Care Act (ACA), posing a threat to patient care access, according to the...

Clinicians Doubt Patient Care Access, Costs Reduction Progress

by Sara Heath

Reducing patient healthcare costs and increasing patient access to care are key priorities in 2019, most clinicians agree, but there isn’t much hope that the industry will achieve these goals, according to a recent poll from...

How Can CMS Address Senior Poverty, Patient Healthcare Costs?

by Sara Heath

Cutting patient healthcare costs will be a key step toward addressing senior poverty, which is ultimately a high priority for the Centers for Medicare & Medicaid Services (CMS), the agency said in a blog post. Late last month, the...

HHS Proposal Reforms Drug Rebates to Reduce Patient Spending

by Sara Heath

HHS has proposed to eliminate drug kickbacks and rebates passed from manufacturer to pharmacy benefits manager (PBM), instead requiring those types of savings to be passed directly to patients. This is a part of the Department’s...

Specialty Drugs Rake in High Out-of-Pocket Costs for Part D Patients

by Sara Heath

Medicare Part D enrollees with serious illness can expect extraordinary out-of-pocket healthcare costs as they seek drugs for their conditions, according to a recent analysis from the Kaiser Family Foundation (KFF). “The findings...

How Can Health Pros Address Cost as Medication Adherence Barrier?

by Sara Heath

As healthcare professionals continue to push for better chronic disease management, they continue to face high healthcare costs as a primary medication adherence barrier. Numerous studies have indicated that drug costs serve as the...

Chronic Disease Management, Diabetes Patient Costs Up $6K

by Sara Heath

Chronic disease management and treatment for individuals with type 1 diabetes can cost patients thousands of dollars each year, primarily due to the increasing cost of insulin, according to a recent report from the Health Care Cost...

Medicare Part B Drug Plan Could Raise Out-of-Pocket Patient Costs

by Sara Heath

An HHS proposal to shift some Medicare Part B drugs to Medicare Part D may decrease overall drug spending, but it could increase out-of-pocket patient costs, data suggests. The HHS proposal would shift Part B drugs to Part D prescription...

Verma: Price Transparency Rule Critical First Step for CMS

by Sara Heath

Healthcare organizations may only need to post chargemaster lists online for now, but that doesn’t mean they can’t create their own initiatives to improve price transparency, said CMS Administrator Seema Verma in a press call...

Price Transparency Rules Take Effect, Slated to Empower Patients

by Sara Heath

As of January 1, 2019, hospitals across the country are responsible for full price transparency, a move that will allow patients to make informed decisions about care access. The mandates come as a part of the 2019 inpatient prospective...

High Out-of-Pocket Costs Hamper Care Access for 30% of Patients

by Sara Heath

Patients are still delaying treatment as a means to manage high out-of-pocket costs, marking a decade-long trend in the medical industry, showed a recent Gallup poll. Twenty-nine percent of US patients delayed healthcare in 2018 because...

Insured Patients See High Premiums, Out-of-Pocket Healthcare Costs

by Sara Heath

Middle-income families spend 11 percent of their annual incomes on out-of-pocket healthcare costs and insurance premiums and deductibles, according to a recent report from the Commonwealth Fund. Using data from the federal Medical...

Industry Groups Call on Protections from Surprise Medical Bills

by Sara Heath

The healthcare industry must adhere to a set of core standards to protect patients from surprise medical bills, said a group of industry leaders in a new position statement. The statement was issued by America’s Health Insurance...

Promoting Patient Choice, Consumer-Centered Care HHS Priorities

by Sara Heath

Improving patient choice, cutting healthcare costs, and supporting consumer-centered care design are key action areas for the Department of Health & Human Services, the agency said in a recent report. The report, “Reforming...

Confronting Indirect Patient Healthcare Cost Hurdles, SDOH

by Sara Heath

Patients face numerous indirect healthcare cost hurdles that impact their ability to access treatment, according to a recent guidance from America’s Essential Hospitals. The guidance, which comes as a part of an entire library of...

Low-Cost Health Plans Come with High Deductibles, Patient Spending

by Sara Heath

Low-income patients can access a health plan with little to no out-of-pocket cost on the ACA health insurance markets, but these plans come with a catch, according to new data from the Kaiser Family Foundation. These subsidized health...

Part D Drug Price Proposal Could Limit Patient Access to Care

by Sara Heath

Utilization management strategies such as formulary tiers and copayments serve as significant barriers to Medicare Part D drugs for many patients managing serious illness, according to a new report conducted by Avalere Health on behalf of...

CMS Drug Price Proposal Aims to Cut Out-of-Pocket Patient Spending

by Sara Heath

CMS has proposed a new drug price model for Medicare Parts C and D that will ideally reduce out-of-pocket patient spending. The policies, which if approved would go into effect in 2020, would impact Medicare Advantage and Medicare Parts C...

X

Sign up for our free newsletter:

Our privacy policy


no, thanks

Continue to site...